Titre : Empreinte moléculaire

Empreinte moléculaire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Functional Status
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Empreinte moléculaire : Questions médicales les plus fréquentes", "headline": "Empreinte moléculaire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Empreinte moléculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-24", "dateModified": "2025-03-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Empreinte moléculaire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Techniques de chimie synthétique", "url": "https://questionsmedicales.fr/mesh/D060326", "about": { "@type": "MedicalCondition", "name": "Techniques de chimie synthétique", "code": { "@type": "MedicalCode", "code": "D060326", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.897.836.249" } } }, "about": { "@type": "MedicalCondition", "name": "Empreinte moléculaire", "alternateName": "Molecular Imprinting", "code": { "@type": "MedicalCode", "code": "D054802", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Zhimin Liu", "url": "https://questionsmedicales.fr/author/Zhimin%20Liu", "affiliation": { "@type": "Organization", "name": "Faculty of Science, Kunming University of Science and Technology, Kunming 650500, China. Electronic address: lab_chem@126.com." } }, { "@type": "Person", "name": "Alessandra Maria Bossi", "url": "https://questionsmedicales.fr/author/Alessandra%20Maria%20Bossi", "affiliation": { "@type": "Organization", "name": "Department of Biotechnology, University of Verona, Strada Le Grazie 15, Verona 37134, Italy." } }, { "@type": "Person", "name": "Jinhua Li", "url": "https://questionsmedicales.fr/author/Jinhua%20Li", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Coastal Environmental Processes and Ecological Remediation, Shandong Key Laboratory of Coastal Environmental Processes, Research Center for Coastal Environmental Engineering and Technology, Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai, 264003, China." } }, { "@type": "Person", "name": "Xian Liu", "url": "https://questionsmedicales.fr/author/Xian%20Liu", "affiliation": { "@type": "Organization", "name": "School of Urban Construction, Wuhan University of Science and Technology, Wuhan, 430065, China." } }, { "@type": "Person", "name": "Lei Zhu", "url": "https://questionsmedicales.fr/author/Lei%20Zhu", "affiliation": { "@type": "Organization", "name": "School of Urban Construction, Wuhan University of Science and Technology, Wuhan, 430065, China. 200844529@qq.com." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Disrupted Brain Functional Status in Patients with Reversible Cerebral Vasoconstriction Syndrome.", "datePublished": "2023-07-06", "url": "https://questionsmedicales.fr/article/37345341", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ana.26724" } }, { "@type": "ScholarlyArticle", "name": "A Novel Grading System for Supraglottic Stenosis Based on Morphology and Functional Status.", "datePublished": "2022-09-02", "url": "https://questionsmedicales.fr/article/36054719", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/lary.30371" } }, { "@type": "ScholarlyArticle", "name": "Functional status analysis of RNH1 in bladder cancer for predicting immunotherapy response.", "datePublished": "2023-08-03", "url": "https://questionsmedicales.fr/article/37537337", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-39827-7" } }, { "@type": "ScholarlyArticle", "name": "Deciphering the Functional Status of Breast Cancers through the Analysis of Their Extracellular Vesicles.", "datePublished": "2023-08-21", "url": "https://questionsmedicales.fr/article/37629204", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms241613022" } }, { "@type": "ScholarlyArticle", "name": "Impact of Preoperative Functional Status on Quality of Life after Cardiac Surgery.", "datePublished": "2022-06-01", "url": "https://questionsmedicales.fr/article/31499539", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/s-0039-1696953" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Technologie", "item": "https://questionsmedicales.fr/mesh/D013672" }, { "@type": "ListItem", "position": 4, "name": "Technologie pharmaceutique", "item": "https://questionsmedicales.fr/mesh/D013678" }, { "@type": "ListItem", "position": 5, "name": "Techniques de chimie synthétique", "item": "https://questionsmedicales.fr/mesh/D060326" }, { "@type": "ListItem", "position": 6, "name": "Empreinte moléculaire", "item": "https://questionsmedicales.fr/mesh/D054802" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Empreinte moléculaire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Empreinte moléculaire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Empreinte moléculaire", "description": "Comment l'empreinte moléculaire est-elle utilisée en diagnostic ?\nQuels tests utilisent l'empreinte moléculaire ?\nL'empreinte moléculaire peut-elle identifier des pathogènes ?\nQuels types d'échantillons sont analysés ?\nL'empreinte moléculaire est-elle précise ?", "url": "https://questionsmedicales.fr/mesh/D054802?mesh_terms=Functional+Status&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Empreinte moléculaire", "description": "Quels symptômes peuvent être détectés par empreinte moléculaire ?\nL'empreinte moléculaire peut-elle détecter des allergies ?\nPeut-on utiliser l'empreinte pour des maladies auto-immunes ?\nQuels biomarqueurs sont liés aux maladies cardiovasculaires ?\nL'empreinte moléculaire peut-elle aider au diagnostic précoce ?", "url": "https://questionsmedicales.fr/mesh/D054802?mesh_terms=Functional+Status&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Empreinte moléculaire", "description": "Comment l'empreinte moléculaire aide-t-elle à la prévention des maladies ?\nPeut-on utiliser l'empreinte pour des dépistages réguliers ?\nL'empreinte moléculaire peut-elle aider à la vaccination ?\nQuels programmes de santé utilisent l'empreinte moléculaire ?\nL'empreinte moléculaire peut-elle réduire les épidémies ?", "url": "https://questionsmedicales.fr/mesh/D054802?mesh_terms=Functional+Status&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Empreinte moléculaire", "description": "L'empreinte moléculaire est-elle utilisée en thérapie ?\nComment l'empreinte moléculaire aide-t-elle en pharmacologie ?\nPeut-on créer des vaccins avec l'empreinte moléculaire ?\nL'empreinte moléculaire aide-t-elle à la délivrance de médicaments ?\nQuels traitements peuvent bénéficier de l'empreinte moléculaire ?", "url": "https://questionsmedicales.fr/mesh/D054802?mesh_terms=Functional+Status&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Empreinte moléculaire", "description": "Quelles complications peuvent survenir avec l'empreinte moléculaire ?\nL'empreinte moléculaire peut-elle causer des effets secondaires ?\nComment minimiser les complications liées à l'empreinte ?\nLes complications affectent-elles la fiabilité des tests ?\nQuelles sont les limites de l'empreinte moléculaire ?", "url": "https://questionsmedicales.fr/mesh/D054802?mesh_terms=Functional+Status&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Empreinte moléculaire", "description": "Quels facteurs influencent l'efficacité de l'empreinte moléculaire ?\nL'âge est-il un facteur de risque pour l'empreinte moléculaire ?\nLes maladies préexistantes affectent-elles l'empreinte ?\nLe mode de vie influence-t-il les résultats de l'empreinte ?\nLes médicaments peuvent-ils interférer avec l'empreinte moléculaire ?", "url": "https://questionsmedicales.fr/mesh/D054802?mesh_terms=Functional+Status&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment l'empreinte moléculaire est-elle utilisée en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de détecter des biomolécules spécifiques dans des échantillons biologiques." } }, { "@type": "Question", "name": "Quels tests utilisent l'empreinte moléculaire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests immunologiques et chromatographiques pour identifier des analytes spécifiques." } }, { "@type": "Question", "name": "L'empreinte moléculaire peut-elle identifier des pathogènes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est utilisée pour détecter des virus et bactéries dans des échantillons cliniques." } }, { "@type": "Question", "name": "Quels types d'échantillons sont analysés ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Sang, urine, salive et autres fluides biologiques peuvent être analysés." } }, { "@type": "Question", "name": "L'empreinte moléculaire est-elle précise ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle offre une haute sélectivité et sensibilité pour les cibles moléculaires." } }, { "@type": "Question", "name": "Quels symptômes peuvent être détectés par empreinte moléculaire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des biomarqueurs associés à des maladies comme le cancer ou des infections." } }, { "@type": "Question", "name": "L'empreinte moléculaire peut-elle détecter des allergies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut identifier des allergènes spécifiques dans des échantillons." } }, { "@type": "Question", "name": "Peut-on utiliser l'empreinte pour des maladies auto-immunes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à détecter des auto-anticorps dans des maladies auto-immunes." } }, { "@type": "Question", "name": "Quels biomarqueurs sont liés aux maladies cardiovasculaires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme la troponine peuvent être détectés par empreinte moléculaire." } }, { "@type": "Question", "name": "L'empreinte moléculaire peut-elle aider au diagnostic précoce ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet une détection précoce de biomarqueurs associés à des maladies." } }, { "@type": "Question", "name": "Comment l'empreinte moléculaire aide-t-elle à la prévention des maladies ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de détecter des biomarqueurs de risque, facilitant des interventions précoces." } }, { "@type": "Question", "name": "Peut-on utiliser l'empreinte pour des dépistages réguliers ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est adaptée pour des dépistages réguliers de certaines maladies." } }, { "@type": "Question", "name": "L'empreinte moléculaire peut-elle aider à la vaccination ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut identifier des cibles pour le développement de nouveaux vaccins." } }, { "@type": "Question", "name": "Quels programmes de santé utilisent l'empreinte moléculaire ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes de dépistage du cancer et de surveillance des infections." } }, { "@type": "Question", "name": "L'empreinte moléculaire peut-elle réduire les épidémies ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à identifier rapidement les agents pathogènes lors d'épidémies." } }, { "@type": "Question", "name": "L'empreinte moléculaire est-elle utilisée en thérapie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle est principalement utilisée pour le diagnostic, mais peut guider des traitements." } }, { "@type": "Question", "name": "Comment l'empreinte moléculaire aide-t-elle en pharmacologie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de concevoir des médicaments ciblant des molécules spécifiques." } }, { "@type": "Question", "name": "Peut-on créer des vaccins avec l'empreinte moléculaire ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être utilisée pour développer des vaccins ciblant des pathogènes." } }, { "@type": "Question", "name": "L'empreinte moléculaire aide-t-elle à la délivrance de médicaments ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut améliorer la délivrance ciblée de médicaments dans l'organisme." } }, { "@type": "Question", "name": "Quels traitements peuvent bénéficier de l'empreinte moléculaire ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements pour le cancer, les infections et les maladies métaboliques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'empreinte moléculaire ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des faux positifs ou négatifs peuvent survenir, affectant le diagnostic." } }, { "@type": "Question", "name": "L'empreinte moléculaire peut-elle causer des effets secondaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle est une méthode d'analyse et ne cause pas d'effets secondaires directs." } }, { "@type": "Question", "name": "Comment minimiser les complications liées à l'empreinte ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "En utilisant des protocoles standardisés et en validant les méthodes de détection." } }, { "@type": "Question", "name": "Les complications affectent-elles la fiabilité des tests ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications peuvent réduire la fiabilité des résultats des tests." } }, { "@type": "Question", "name": "Quelles sont les limites de l'empreinte moléculaire ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les limites incluent la spécificité et la sensibilité, pouvant varier selon les cibles." } }, { "@type": "Question", "name": "Quels facteurs influencent l'efficacité de l'empreinte moléculaire ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "La nature de la molécule cible et les conditions de synthèse des polymères." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour l'empreinte moléculaire ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "L'âge peut influencer la concentration de biomarqueurs dans les échantillons." } }, { "@type": "Question", "name": "Les maladies préexistantes affectent-elles l'empreinte ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent modifier les niveaux de biomarqueurs détectés par empreinte." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il les résultats de l'empreinte ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme l'alimentation et l'exercice peuvent affecter les biomarqueurs." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils interférer avec l'empreinte moléculaire ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent altérer les niveaux de biomarqueurs dans les tests." } } ] } ] }

Sources (10000 au total)

Disrupted Brain Functional Status in Patients with Reversible Cerebral Vasoconstriction Syndrome.

The aim of this study was to investigate the functional networks in subjects with reversible cerebral vasoconstriction syndrome (RCVS) using resting-state functional magnetic resonance imaging (rs-fMR... We prospectively recruited patients with RCVS and healthy controls (HCs) between February 2017 and April 2021. The rs-fMRI data were analyzed using graph theory methods. We compared node-based global ... A total of 104 RCVS patients and 93 HCs were included in the final analysis. We identified significantly decreased local efficiency of the left dorsal anterior insula (dAI; p = 0.0005) in RCVS patient... The significantly lower local efficiency of the left dAI, suggestive of impaired central autonomic modulation, was negatively correlated with vasoconstriction severity, which is highly plausible for t...

A Novel Grading System for Supraglottic Stenosis Based on Morphology and Functional Status.

Currently, no classification system exists to grade the severity of supraglottic stenosis. The aim of this investigation was to (1) develop a novel grading system for supraglottic stenosis that can bo... A retrospective analysis of patients with supraglottic stenosis at three institutions from 2010-2021 was conducted. After demographic data were collected, two focus group meetings of five laryngologis... Twenty-eight patients were included. Epiglottic and arytenoid fixation were morphological features associated with worse functional outcomes such as requiring a G-tube or a tracheostomy, respectively.... A grading system for supraglottic stenosis has been proposed with strong inter-rater and intra-rater reliabilities. The proposed system has the advantage of being descriptive of both patient functiona... 3-According to the Oxford Center for Evidence-Based Medicine 2011 level of evidence guidelines, this non-randomized retrospective cohort study is classified as level 3 evidence Laryngoscope, 133:1442-...

Impact of Preoperative Functional Status on Quality of Life after Cardiac Surgery.

With increasing importance, health-related quality of life (HRQoL) has become a crucial outcome measure of cardiac surgery. The aim of this study was to assess the dynamics of HRQoL change within 12 m... The cohort of this prospective study included 164 consecutive patients who underwent elective surgery. HRQoL was assessed on the basis of the Short-Form 36 questionnaire at three different times: upon... In general, physical and mental health status improved within the first year after cardiac surgery. However, after 12 months, 7.9 and 21.2% of patients had clinically significant poorer physical (PCS)... Although we were able to demonstrate a general improvement in the HRQoL following cardiac surgery, in one-fifth of patients, there was no recovery of mental health status even after 1 year. As this ef...

COVID-19 does not influence functional status after ARDS therapy.

Health-related quality of life after surviving acute respiratory distress syndrome has come into focus in recent years, especially during the coronavirus disease 2019 pandemic.... A total of 144 patients with acute respiratory distress syndrome caused by COVID-19 or of other origin were recruited in a randomized multicenter trial.... Clinical data during intensive care treatment and data up to 180 days after study inclusion were collected. Changes in the Sequential Organ Failure Assessment score were used to quantify disease sever... Mortality rate and morbidity after 180 days were compared between patients with and without COVID-19. Independent risk factors associated with high disability were identified using a binary logistic r... The SOFA score at day 5 was an independent risk factor for high disability in both groups, and score dynamic within the first 5 days significantly impacted disability in the non-COVID group. Mortality... Resolution of organ dysfunction within the first 5 days significantly impacts long-term morbidity. Acute respiratory distress syndrome caused by COVID-19 was not associated with increased mortality or...

Interrater reliability of chart-based assessment of functional impairment after pediatric injury using the functional status scale.

Functional impairment has been proposed as an alternative outcome for quality improvement in pediatric trauma. The functional status scale (FSS) has been used in studies of injured children, but has o... A retrospective cohort of admissions to a Level I pediatric trauma center between July 2020 and June 2021 was analyzed. Two physicians and two nurse registrars reviewed charts to obtain measures of si... The cohort included 443 children with a mean age of 7.4 years (standard deviation, 5.4 years) and median Injury Severity Score of 9 (interquartile range, 5-12). The median time per chart to assess FSS... Chart-based FSS assessment is feasible and reliable, but may require more detailed review for patients with higher level of impairment that require allied health therapy. Validation of chart-based ass... Prognostic/Epidemiological, Level III....

Functional Status is Key to Long-term Survival in Emergency General Surgery Conditions.

Emergency General Surgery (EGS) conditions in older patients constitutes a substantial public health burden due to high morbidity and mortality. We sought to utilize a supervised machine learning meth... We identified community dwelling participants admitted for EGS conditions from the Medicare Current Beneficiary Survey linked with claims (1992-2013). We categorized three binary domains of multimorbi... We identified 1960 patients (median age 79 [interquartile range [IQR]: 73, 85], 59.5% female). The CART model identified the presence of functional limitations as the primary splitting variable. The l... More than the presence of chronic conditions or geriatric syndromes, functional limitations are an important predictor of long-term survival and must be included in presurgical assessment....

Long-term cognitive and functional status in Danish ICU patients with COVID-19.

ICU admission due to COVID-19 may result in cognitive and physical impairment. We investigated the long-term cognitive and physical status of Danish ICU patients with COVID-19.... We included all patients with COVID-19 admitted to Danish ICUs between March 10 and May 19, 2020. Patients were the contacted prospectively at 6 and 12 months for follow-up. Our primary outcomes were ... A total of 326 patients were included. The 6- and 12-month mortality was 37% and 38%, respectively. Among the 204 six-month survivors, 105 (51%) participated in the 6-month follow-up; among the 202 tw... Long-term cognitive, functional impairment was found in up to one in four of patients surviving intensive care for COVID-19. Fatigue was present in nearly half the survivors at both 6 and 12 months. H...

Dependent functional status is a risk factor for complications after surgery for diverticulitis coli.

Functional dependence (FD) is associated with poor postoperative outcomes. We investigated the influence of FD on the postoperative outcomes of colectomy.... The 2012-2020 National Surgical Quality Improvement Program was queried for patients who had undergone colectomy for diverticulitis. The patients were analyzed based on FD or functionally independent ... Of the 62,409 patients 991 (1.6%) were FD. Compared to FI patients, those with FD were older (mean age, 72.7 vs. 59.1 years, p < 0.001), with higher comorbidities and more unplanned open procedures (7... Dependent functional status is an independent risk factor for complications after surgery for diverticulitis....